JP2013521273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521273A5 JP2013521273A5 JP2012555537A JP2012555537A JP2013521273A5 JP 2013521273 A5 JP2013521273 A5 JP 2013521273A5 JP 2012555537 A JP2012555537 A JP 2012555537A JP 2012555537 A JP2012555537 A JP 2012555537A JP 2013521273 A5 JP2013521273 A5 JP 2013521273A5
- Authority
- JP
- Japan
- Prior art keywords
- done
- maximum
- diffraction spectrum
- milling method
- ray spectral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000370 | 2010-03-05 | ||
| ITMI2010A000370A IT1398550B1 (it) | 2010-03-05 | 2010-03-05 | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| PCT/IB2011/050933 WO2011107970A2 (en) | 2010-03-05 | 2011-03-04 | Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521273A JP2013521273A (ja) | 2013-06-10 |
| JP2013521273A5 true JP2013521273A5 (https=) | 2014-01-30 |
| JP5932669B2 JP5932669B2 (ja) | 2016-06-08 |
Family
ID=42697389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012555537A Expired - Fee Related JP5932669B2 (ja) | 2010-03-05 | 2011-03-04 | リファキシミン粉体、その調製方法、及び長期持続効果を得るために有用な前記リファキシミン含有徐放性組成物 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8748447B2 (https=) |
| EP (1) | EP2542225B1 (https=) |
| JP (1) | JP5932669B2 (https=) |
| KR (1) | KR101663491B1 (https=) |
| CN (1) | CN102781432B (https=) |
| AU (1) | AU2011222432B2 (https=) |
| BR (1) | BR112012021681A8 (https=) |
| CA (1) | CA2787123C (https=) |
| CL (1) | CL2012002124A1 (https=) |
| CO (1) | CO6551760A2 (https=) |
| DK (1) | DK2542225T3 (https=) |
| EA (1) | EA022324B1 (https=) |
| ES (1) | ES2496771T3 (https=) |
| HR (1) | HRP20140876T1 (https=) |
| IL (1) | IL220792A (https=) |
| IT (1) | IT1398550B1 (https=) |
| MX (1) | MX2012010233A (https=) |
| NZ (1) | NZ602230A (https=) |
| PL (1) | PL2542225T3 (https=) |
| PT (1) | PT2542225E (https=) |
| RS (1) | RS53609B1 (https=) |
| SG (1) | SG182523A1 (https=) |
| SI (1) | SI2542225T1 (https=) |
| TN (1) | TN2012000362A1 (https=) |
| UA (1) | UA107208C2 (https=) |
| WO (1) | WO2011107970A2 (https=) |
| ZA (1) | ZA201205537B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| EP2401282B2 (en) | 2009-12-28 | 2017-01-04 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| EP2544660B1 (en) * | 2010-03-10 | 2018-06-13 | Lupin Limited | Rifaximin ready-to-use suspension |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| US9849090B2 (en) | 2012-12-12 | 2017-12-26 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of rifaximin |
| US10572631B2 (en) | 2014-08-01 | 2020-02-25 | Bioxcel Corporation | Methods for reformulating and repositioning pharmaceutical data and devices thereof |
| WO2016063289A2 (en) * | 2014-10-22 | 2016-04-28 | Strides Arcolab Limited | Pharmaceutical tablet compositions comprising rifaximin |
| AU2016259897A1 (en) * | 2015-05-08 | 2017-08-17 | Wockhardt Limited | Stable pharmaceutical compositions comprising antibacterial agent |
| TR201816080T4 (tr) | 2016-03-24 | 2018-11-21 | Sandoz Ag | Ri̇faksi̇mi̇n alfa & delta i̇çeren farmasöti̇k bi̇leşi̇m |
| EP3536311B1 (en) | 2016-03-24 | 2021-12-22 | Sandoz AG | Storage stable composition comprising rifaximin alpha |
| JP7027412B2 (ja) * | 2016-09-30 | 2022-03-01 | サリックス ファーマスーティカルズ，インコーポレーテッド | リファキシミンの固体分散体の形態 |
| WO2020208140A1 (en) * | 2019-04-12 | 2020-10-15 | Sandoz Ag | Rifaximin-containing granules |
| JP7825575B2 (ja) | 2020-06-26 | 2026-03-06 | バウシュ ヘルス アイルランド リミテッド | 標的化放出リファキシミン組成物 |
| US20240415809A1 (en) * | 2021-10-19 | 2024-12-19 | Zydus Lifesciences Limited | Pharmaceutical combinations |
| WO2025170483A1 (ru) * | 2024-02-07 | 2025-08-14 | Общество с ограниченной ответственностью "БИННОФАРМ ГРУПП" | Фармацевтическая композиция, обладающая антибиотической активностью |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| DE3113139A1 (de) | 1981-04-01 | 1982-10-21 | Smit Transformatoren B.V., 6500 Nijmegen | "trockentransformator oder drosselspule mit luftkuehlung" |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| US5356625A (en) | 1986-08-28 | 1994-10-18 | Enzacor Properties Limited | Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| GB8816620D0 (en) | 1988-07-13 | 1988-08-17 | Lepetit Spa | Rifapentine hydrohalides |
| DE69111607T2 (de) | 1990-06-29 | 1995-12-21 | Lepetit Spa | Reine kristalline form von rifapentin. |
| IT1253711B (it) | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
| IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| EP2060183A3 (en) | 1996-10-16 | 2009-06-03 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| IT1290679B1 (it) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| US20030059471A1 (en) | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
| US20030157174A1 (en) | 2000-03-23 | 2003-08-21 | Takayuki Tsukuda | Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component |
| US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
| AU2002212340B2 (en) | 2000-10-31 | 2006-12-14 | Sandoz Ag | Crystalline forms of venlafaxine hydrochloride |
| IL156055A0 (en) | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| US7902206B2 (en) | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
| US7906542B2 (en) | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
| US20080262024A1 (en) | 2003-11-07 | 2008-10-23 | Giuseppe Claudio Viscomi | Rifaximin compositions and method of use |
| US7923553B2 (en) | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
| US20050196418A1 (en) | 2004-03-04 | 2005-09-08 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
| PT1698630E (pt) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
| WO2008035109A1 (en) | 2006-09-22 | 2008-03-27 | Cipla Limited | Rifaximin |
| ITMI20071241A1 (it) | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
| PL2011486T5 (pl) | 2007-07-06 | 2016-09-30 | Lupin Ltd | Farmaceutyczne kompozycje rifaksyminy |
| WO2009008006A2 (en) | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
| WO2009008005A1 (en) | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions of rifaximin |
| US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
| GEP20135898B (en) * | 2008-02-25 | 2013-08-12 | Salix Pharmaceuticals Ltd | Rifaximin forms and usage |
| US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| WO2010044093A1 (en) | 2008-10-16 | 2010-04-22 | Strides Arcolab Limited | Formulations containing rifaximin |
| KR101906177B1 (ko) | 2008-12-10 | 2018-10-10 | 시플라 리미티드 | 리팍시민 복합체 |
| IT1397617B1 (it) | 2009-04-20 | 2013-01-18 | Alfa Wassermann Spa | Nuovi derivati della rifamicina |
| US8772242B2 (en) | 2009-10-26 | 2014-07-08 | Thomas Julius Borody | Therapy for enteric infections |
| GEP201706693B (en) | 2009-10-27 | 2017-07-10 | Lupin Ltd | Solid dispersion of rifaximin |
| WO2011061748A1 (en) | 2009-11-19 | 2011-05-26 | Strides Arcolab Limited | Rifaximin premix |
| CA2781580A1 (en) | 2009-11-23 | 2011-05-26 | Cipla Limited | Topical foam composition |
| CN102724961A (zh) | 2009-11-23 | 2012-10-10 | 希普拉有限公司 | 局部泡沫组合物 |
| EP2401282B2 (en) | 2009-12-28 | 2017-01-04 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
| CN101773465B (zh) | 2010-01-19 | 2012-11-07 | 南京泛太化工医药研究所 | 以氨基酸为稳定剂的聚合物胶束载药系统 |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| EP2544660B1 (en) | 2010-03-10 | 2018-06-13 | Lupin Limited | Rifaximin ready-to-use suspension |
| MX2012013945A (es) | 2010-06-03 | 2013-05-06 | Salix Pharmaceuticals Ltd | Nuevas formas de rifaximina y usos de las mismas. |
| CA2802874A1 (en) | 2010-06-16 | 2011-12-22 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| PH12013500082B1 (en) | 2010-07-12 | 2019-06-28 | Salix Pharmaceuticals Ltd | Formulations of rifaximin and uses thereof |
| US8759513B2 (en) | 2010-09-13 | 2014-06-24 | Sequent Scientific Limited | Polymorphic form of rifaximin and process for its preparation |
| CN103221032A (zh) | 2010-09-13 | 2013-07-24 | 西普拉有限公司 | 药物组合物 |
| IT1403847B1 (it) | 2010-09-22 | 2013-11-08 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina e loro uso. |
| WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
| MX350448B (es) | 2011-02-11 | 2017-09-07 | Salix Pharmaceuticals Ltd | Formas de rifaximina y usos de las mismas. |
| EP2705042A1 (en) | 2011-05-02 | 2014-03-12 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
| ITMI20110890A1 (it) | 2011-05-19 | 2012-11-20 | A M S A Anonima Materie Sint & Affini S P A | Polimorfo di rifaximina e processo per la sua preparazione |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| CA2876737A1 (en) | 2012-06-13 | 2013-12-19 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| US9849090B2 (en) | 2012-12-12 | 2017-12-26 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of rifaximin |
| ITMI20131307A1 (it) | 2013-08-02 | 2015-02-02 | A M S A Anonima Materie Sint & Affini S P A | Processo per la preparazione di refaximina k |
-
2010
- 2010-03-05 IT ITMI2010A000370A patent/IT1398550B1/it active
-
2011
- 2011-03-04 DK DK11714663.9T patent/DK2542225T3/da active
- 2011-03-04 HR HRP20140876AT patent/HRP20140876T1/hr unknown
- 2011-03-04 RS RS20140619A patent/RS53609B1/sr unknown
- 2011-03-04 KR KR1020127022961A patent/KR101663491B1/ko not_active Expired - Fee Related
- 2011-03-04 EA EA201290734A patent/EA022324B1/ru unknown
- 2011-03-04 AU AU2011222432A patent/AU2011222432B2/en not_active Ceased
- 2011-03-04 PL PL11714663T patent/PL2542225T3/pl unknown
- 2011-03-04 NZ NZ602230A patent/NZ602230A/xx not_active IP Right Cessation
- 2011-03-04 WO PCT/IB2011/050933 patent/WO2011107970A2/en not_active Ceased
- 2011-03-04 CA CA2787123A patent/CA2787123C/en active Active
- 2011-03-04 BR BR112012021681A patent/BR112012021681A8/pt not_active Application Discontinuation
- 2011-03-04 SI SI201130298T patent/SI2542225T1/sl unknown
- 2011-03-04 PT PT117146639T patent/PT2542225E/pt unknown
- 2011-03-04 EP EP11714663.9A patent/EP2542225B1/en active Active
- 2011-03-04 MX MX2012010233A patent/MX2012010233A/es unknown
- 2011-03-04 JP JP2012555537A patent/JP5932669B2/ja not_active Expired - Fee Related
- 2011-03-04 US US13/582,676 patent/US8748447B2/en active Active
- 2011-03-04 ES ES11714663.9T patent/ES2496771T3/es active Active
- 2011-03-04 CN CN201180012550.XA patent/CN102781432B/zh not_active Expired - Fee Related
- 2011-03-04 SG SG2012051975A patent/SG182523A1/en unknown
- 2011-04-03 UA UAA201208484A patent/UA107208C2/uk unknown
-
2012
- 2012-07-05 IL IL220792A patent/IL220792A/en active IP Right Grant
- 2012-07-17 TN TNP2012000362A patent/TN2012000362A1/en unknown
- 2012-07-23 ZA ZA2012/05537A patent/ZA201205537B/en unknown
- 2012-07-30 CO CO12127400A patent/CO6551760A2/es not_active Application Discontinuation
- 2012-07-31 CL CL2012002124A patent/CL2012002124A1/es unknown
-
2014
- 2014-04-24 US US14/261,337 patent/US9498442B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521273A5 (https=) | ||
| AP2014007436A0 (en) | A novel 1,2,3,4,-Tetrahydroquinoline derivative useful for the treatment of diabetes | |
| JP2014102408A5 (https=) | ||
| JP2012190484A5 (https=) | ||
| JP2012081521A5 (https=) | ||
| WO2015008218A3 (en) | Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant | |
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| GB2485667B (en) | Controlling hydrogen-deuterium exchange on a spectrum by spectrum basis | |
| JP2012035359A5 (https=) | ||
| IL216935A0 (en) | Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof | |
| EP2760812B8 (en) | Process for producing 2,3,3,3-tetrafluoropropene | |
| MX344858B (es) | Nuevo procedimiento para la síntesis de rifaximina y una nueva forma pseudocristalina de rifaximina obtenida con el mismo. | |
| JP2013528272A5 (https=) | ||
| JP2011234359A5 (https=) | ||
| PH12015502122A1 (en) | Sovaprevir polymorphs and methods of manufacturing thereof | |
| WO2015022265A3 (en) | Cyclobutyl carboxamides as nematicides | |
| EP2687520A4 (en) | PROCESS FOR PREPARING A 1,2-BENZISOTHIAZOL-3-ON COMPOUND | |
| IL232194A0 (en) | An improved iontophoretic cross-linking mixture for use in the treatment of keratoconus | |
| EP2687519A4 (en) | PROCESS FOR PRODUCING 1,2-BENZISOTHIAZOL-3-ONE COMPOUNDS | |
| EP2883870B8 (en) | Method for producing 1,4-benzoxazine compound | |
| WO2016016774A8 (en) | Crystalline forms of canagliflozin | |
| JP2013531183A5 (https=) | ||
| JP2014507254A5 (https=) | ||
| WO2013121439A3 (en) | Garenoxacin mesylate, process for preparation thereof, and crystalline form thereof. | |
| PL2771328T3 (pl) | Sposób otrzymywania 1,2-benzizotiazolin-3-onu |